Prot #R2810-ONC-1806: Cemiplimab Survivorship Epidemiology (CASE) Study

Project: Research project

Project Details

StatusActive
Effective start/end date12/5/1912/5/22

Funding

  • inVentiv Health Clinical (Prot #R2810-ONC-1806)
  • Regeneron Pharmaceuticals, Inc. (Prot #R2810-ONC-1806)